Published in Blood Weekly, June 11th, 2009
"Prograf + MMF has been an accepted and successful immunosuppressant regimen for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.